First-trimester maternal serum biochemical indicators in Down syndrome

Area of Science:

• Biochemistry
• Genetics
• Maternal-Fetal Medicine

Background:

• Down syndrome is a genetic disorder associated with specific biochemical markers in maternal serum.
• Early detection of Down syndrome can inform clinical management and parental counseling.

Purpose of the Study:

• To investigate the concentrations of key biochemical markers in early maternal serum from pregnancies with Down syndrome.
• To compare these marker levels against unaffected pregnancies to identify potential screening indicators.

Main Methods:

• Maternal serum samples from 21 pregnancies with Down syndrome (19 first-trimester, 2 at 14 weeks) were matched with 63 control samples.
• Concentrations of alpha-fetoprotein (AFP), unconjugated estriol (uE3), human chorionic gonadotrophin (hCG), pregnancy-specific beta 1-glycoprotein (SP1), and placental alkaline phosphatase (PALP) were measured.

Main Results:

• Median ratios for Down syndrome pregnancies versus controls were: AFP 0.71, uE3 0.67, hCG 1.43, SP1 0.79, and PALP 0.92.
• Observed differences in marker concentrations between affected and unaffected pregnancies were not statistically significant.
• Trends for AFP, uE3, and hCG in affected pregnancies corroborated earlier first-trimester findings.

Conclusions:

• Early maternal serum marker levels, including AFP, uE3, and hCG, show trends consistent with previous studies in Down syndrome pregnancies.
• While individual marker differences were not significant, these trends may contribute to combined risk assessment models.
• Further research with larger cohorts may elucidate the predictive value of these markers in early Down syndrome screening.